Medicus Pharma Proposes $135 Million SkinJect SPAC Combination

The nonbinding letter contemplates a pre-money enterprise valuation and concurrent equity financing, but the financing terms and SPAC’s identity remain undisclosed.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.